申请人:University of Tennessee Research Foundation
公开号:US10662148B2
公开(公告)日:2020-05-26
This invention provides substituted acylanilide compounds and uses thereof in treating a variety of diseases or conditions in a subject including, inter alia, a muscle wasting disease and/or disorder such as Duchenne muscular dystrophy or Becker muscular dystrophy.
本发明提供了取代的酰基苯胺化合物及其在治疗受试者多种疾病或病症中的用途,其中包括肌肉萎缩疾病和/或紊乱,如杜兴氏肌肉萎缩症或贝克氏肌肉萎缩症。